Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Amprenavir
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Agenerase 150mg capsules
0503010I0BBAAAA
|
Agenerase | Amprenavir | Infections | No data available |
|
Agenerase 15mg/ml oral solution
0503010I0BBACAC
|
Agenerase | Amprenavir | Infections | No data available |
|
Agenerase 50mg capsules
0503010I0BBABAB
|
Agenerase | Amprenavir | Infections | No data available |
|
Amprenavir 150mg capsules
0503010I0AAAAAA
|
Amprenavir | Amprenavir | Infections | No data available |
|
Amprenavir 15mg/ml oral solution sugar free
0503010I0AAACAC
|
Amprenavir | Amprenavir | Infections | No data available |
|
Amprenavir 50mg capsules
0503010I0AAABAB
|
Amprenavir | Amprenavir | Infections | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.